This is the September edition of our spinout tracker (you can access previous months here). The list is updated weekly throughout the month.
We welcome submissions from tech transfer offices with information on their latest spinouts.
If you would like one of your portfolio companies considered for inclusion in a future list, please send us an email. Eligible companies must be early-stage. However, they need not have raised capital yet and can use this list to advertise that they are open to investors.
| Added | Company | University | Location | Sector | Technology | Round | Amount ($m) | Investors | Amount ($m) |
|---|---|---|---|---|---|---|---|---|---|
| 09/06/2024 | Lucid Genomics | Charite University Hospital | Germany | Health | AI-digital health platform that extracts genomic information to improve diagnostics and drug discovery | Pre-seed | 1.45 | Caesar Ventures; BIF Partners; another.vc; MPF Accelerator | $0 – $5m |
| 09/06/2024 | Oxylus Energy | Yale University | US | Cleantech | carbon utilisation technology for the production of green fuels and chemical feedstocks | Seed | 4.5 | Toyota Ventures; Azolla Ventures; Earth Foundry; Connecticut Innovations | $0 – $5m |
| 09/06/2024 | Infinigence AI | Tsinghua University | China | Information Technology | developer of hardware to optimise large language model training and inference | Series A | 70.2 | Qiming Venture Partners; Hongtai Aplus; Lenovo Capital & Incubator Group; Xiaomi Corp. | $70.1m – $75m |
| 6/9//2024 | HDAX | University of Toronto | Canada | Health | molecular recognition technology for the treatment of disease | Seed | 3.2 | SeedFolio; FACIT; Toronto Innovation Acceleration Partners; Eos Bioinnovation; Ontario Centre of Innovation | $0 – $5m |
| 09/06/2024 | Mantel | Massachussetts Institute of Technology | US | Cleantech | developer of molten-salt-based carbon capture technology | Series A | 30 | Shell Ventures; Eni Next; Engine Ventures; New Climate Ventures; Hartree; bp Ventures; Arosa Ventures; Yale Ventures; Newlab; MCJ Collective | $25.1m – $30m |
| 09/06/2024 | Ellethermo | Tokyo Institute of Technology | Japan | Information Technology | semiconductor-sensitised thermal cell developer | Pre-series A | 2.5 | Hulic; KDDI Green Partners Fund; Keio Innovation Initiative; Mirai Souzo; Mitsubishi UFJ Capital; Mizuho Capital | $0 – $5m |
| 09/06/2024 | Awen Oncology | Bangor University; Cardiff University | UK | Health | developer of oncology treatments taht target specific proteins in cancer cells | Undisclosed | Undisclosed | Development Bank of Wales; Start Codon | Undisclosed |
| 09/06/2024 | ScubaTx | Newcastle University | UK | Health | developer of organ transplant technology | Undisclosed | 1.8 | Praetura Ventures | $0 – $5m |
| 09/06/2024 | Mindgard | Lancaster University | UK | Information Technology | AI security platform | Seed | 4 | IQ Capital; Lakestar | $0 – $5m |
| 13/9/24 | CardiaTec | University of Cambridge | UK | Health | AI-driven platform that uses multiomics data to find therapeutics for cardiovascular disease | Seed | 6.5 | Montage Ventures; Continuum Health Ventures, Laidlaw Ventures, Apex Ventures | $5.1m – $10m |
| 13/9/24 | Brightflow | Université Paris-Est Créteil | France | Health | developer of a medical device to support treatment of right ventricular heart failure | Series A | 18 | VIVES Partners; UI Investissement; BNP Paribas Development | $15.1m – $20m |
| 13/9/24 | Myostellar | Monash University | Australia | Health | developer of therapeutics for skeletal muscle regeneration | Undisclosed | 0.34 | Brandon Capital | $0 – $5m |
| 13/9/24 | GILZrx | Monash University | Australia | Health | novel drug alternative to glucocorticoids in the treatment of inflammatory and autoimmune diseases | Undisclosed | 0.34 | Brandon Capital | $0 – $5m |
| 13/9/24 | Exergy3 | University of Edinbriugh | UK | Cleantech | high temperature thermal energy storage technology | Pre-seed | 1.3 | Zero Carbon Capital | $0 – $5m |
| 13/9/24 | Allogenetics | Medical School Hanover | Germany | Health | deveoloper of an alternative to immunosuppressants to prevent organ failure in transplants | Seed | 3.7 | NBank Capital; Carma Fund I | $0 – $5m |
| 19/9/24 | Find Therapeutics | Strasbourg University | Canada | Health | developer of therapies to treat inflammatory autoimmune diseases | Undisclosed | 8.1 | Investissement Quebec; CTI Life Sciences Fund; adMare BioInnovations | $5.1m – $10m |
| 19/9/24 | Evoralis | University of Cambridge | UK | Cleantech | developer of plastic-depolymerising enzymes for recycling textiles and other plastics | Seed | 3.3 | LIFTT; Cambridge Enterprise Ventures; Parkwalk Advisors; Backbone Ventures; Circular Plastics Accelerator; Archpelago Ventures | $0 – $5m |
| 19/9/24 | Alesi Surgical | Cardiff University | UK | Health | technology that manages smoke created by surgical tools in operating theatres | Undisclosed | 6.6 | Mercia Ventures; IP Group; Panakes Partners | $5.1m – $10m |
| 19/9/24 | Syntax Bio | University of Illinois Chicago | US | Health | preclinical stage biotechnology company focused on generating therapeutic-grade cells from stem cells | Undisclosed | Undisclosed | Astellas Venture Management; Illumina Ventures; DCVCBio; Civilization Ventures, EGB Capital; Portal Innovations | Undisclosed |
| 19/9/24 | Symphera | Technical University of Munich | Germany | Health | developer of laparoscopic device that allows surgeon to do entire surgery with one device | Seed | 2.7 | High-Tech Gruenderfonds; Bayern Capital; Carma Fund; UnternehmenTUM Funding for Innovators; Stern Stewart Ventures; IRCAD | $0 – $5m |
| 19/9/24 | Tanai Therapeutics | VIB; Ghent University | Belgium | Health | oral therapeutic for obesity | Undisclosed | Undisclosed | Novo Nordisk; BioGeneration Ventures; V-Bio Ventures; Qbic; VIB | Undisclosed |
| 19/9/24 | MiAlgae | Herriot-Watt University | UK | Industrial | grows omega-3 without reliance on wild caught fish | Undisclosed | 18.6 | SWEN Blue Ocean; Clay Capital; Rabo Ventures;Scottish Entperise; Social Investment Scotland Ventures; Old College Capital | $15.1m – $20m |
| 20/9/24 | AI-Sight | University of Liverpool | UK | Health | AI system for diabetic retinal screening | Undisclosed | Undisclosed | Pitalia Capital; Deepbridge Capital | Undisclosed |
| 20/9/24 | Crystal Semiconductors | Universidad Autónoma de Madrid | Spain | Industrial | next-generation X-ray and gamma ray sensor manufacturing | Pre-seed | Undisclosed | Undisclosed | Undisclosed |
| 27/9/24 | Deakin Bio | University of Liverpool | UK | Cleantech | bio-based alternative to ceramic tiles that lowers carbon footprint | Undisclosed | 0.93 | Green Angel Investors | $0 – $5m |
| 27/9/24 | FluoRok | University of Oxford | UK | Cleantech | cheap and environmentally friendly access to fluorochemicals | Undisclosed | 9.8 | BGF; Green Generation Fund; Volta Energy Technologies; Oxford Science Enterprises; Excellis Holding | $5.1m – $10m |
| 30/9/24 | FathomX | National University of Singapore | Singapore | Health | AI-based screening procedure for mammograms | Undisclosed | 5 | Undisclosed | $0 – $5m |
| 30/9/24 | Invizius | University of Edinburgh | UK | Health | treatment for patiients who have inflammatory reactions during dialysis | Undisclosed | 1.2 | Mercia Ventures; Calculus Capital; Syensqo; Old College Capital; Scottish Enterprise | $0 – $5m |
| 30/9/24 | Letta | University of Califoria, Berkeley | US | Information Technology | memory management technology for large language models | Seed | 10 | Astasia Myers | $5.1m – $10m |
| 30/9/24 | PACT | University of Cambridge | UK | Cleantech | developer of biomaterials for use in fashion sector | Seed | 12 | Hoxton Ventures; ReGen Ventures; Celsius Industries; Polytechnique Ventures | $10.1m – $15m |
| 30/9/24 | Puraffinity | Imperial College London | UK | Cleantech | developer of absorbent materials to remove PFAS from water | Series A | 22.8 | Octupus Ventures; HG Ventures; Kindred Capital; Verve Ventures; Universal Materials Incubator; BGF | $20.1m – $25m |
